These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8688495)

  • 1. A genetically engineered fusion protein M4/TNF with increased bifunctional activity refolded in the presence of protein disulfide isomerase.
    Yang J; Raju R; Sharma R; Xiang J
    Hum Antibodies Hybridomas; 1995; 6(4):129-36. PubMed ID: 8688495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genetically engineered single-chain FV/TNF molecule possesses the anti-tumor immunoreactivity of FV as well as the cytotoxic activity of tumor necrosis factor.
    Yang J; Moyana T; Xiang J
    Mol Immunol; 1995 Aug; 32(12):873-81. PubMed ID: 7565814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting gamma interferon to tumor cells by a genetically engineered fusion protein secreted from myeloma cells.
    Xiang J; Qi Y; Cook D; Moyana T
    Hum Antibodies Hybridomas; 1996; 7(1):2-10. PubMed ID: 8886831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genetically engineered single-gene-encoded anti-TAG72 chimeric antibody secreted from myeloma cells.
    Qi Y; Xiang J
    Hum Antibodies Hybridomas; 1995; 6(4):161-6. PubMed ID: 8688499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.
    Scherf U; Benhar I; Webber KO; Pastan I; Brinkmann U
    Clin Cancer Res; 1996 Sep; 2(9):1523-31. PubMed ID: 9816329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli.
    Cao P; Mei JJ; Diao ZY; Zhang Sq
    Protein Expr Purif; 2005 May; 41(1):199-206. PubMed ID: 15802238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.
    Urieto JO; Liu T; Black JH; Cohen KA; Hall PD; Willingham MC; Pennell LK; Hogge DE; Kreitman RJ; Frankel AE
    Protein Expr Purif; 2004 Jan; 33(1):123-33. PubMed ID: 14680969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic engineering of a recombinant fusion possessing anti-tumor F(ab')2 and tumor necrosis factor.
    Xiang J; Moyana T; Qi Y
    J Biotechnol; 1997 Feb; 53(1):3-12. PubMed ID: 9165756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glutaredoxin and protein disulfide isomerase on the glutathione-dependent folding of ribonuclease A.
    Ruoppolo M; Lundström-Ljung J; Talamo F; Pucci P; Marino G
    Biochemistry; 1997 Oct; 36(40):12259-67. PubMed ID: 9315864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein disulfide isomerase mutant lacking its isomerase activity accelerates protein folding in the cell.
    Hayano T; Hirose M; Kikuchi M
    FEBS Lett; 1995 Dec; 377(3):505-11. PubMed ID: 8549786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction, expression, and characterization of a new targeted bifunctional fusion protein: tumstatin45-132-TNF.
    Luo YQ; Wang LH; Ma XL; Kong JX; Jiao BH
    IUBMB Life; 2006 Nov; 58(11):647-53. PubMed ID: 17085384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-level expression and purification of the recombinant diphtheria fusion toxin DTGM for PHASE I clinical trials.
    Frankel AE; Ramage J; Latimer A; Feely T; Delatte S; Hall P; Tagge E; Kreitman R; Willingham M
    Protein Expr Purif; 1999 Jun; 16(1):190-201. PubMed ID: 10336877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression, purification and refolding of streptavidin-tagged human tumor necrosis factor-alpha fusion protein].
    Xu CX; Hu ZM; Li JL; Gao JM
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):412-5. PubMed ID: 19304513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional antibody production using cell-free translation: effects of protein disulfide isomerase and chaperones.
    Ryabova LA; Desplancq D; Spirin AS; Plückthun A
    Nat Biotechnol; 1997 Jan; 15(1):79-84. PubMed ID: 9035111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of soluble expression in Escherichia coli cytoplasm by a protein disulfide isomerase gene fusion system.
    Liu Y; Zhao TJ; Yan YB; Zhou HM
    Protein Expr Purif; 2005 Dec; 44(2):155-61. PubMed ID: 15882951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production in Escherichia coli of human thymosin beta 4 as chimeric protein with human tumor necrosis factor.
    Tsuji Y; Kitahara-Tanabe N; Noguchi K; Gatanaga T; Mizuno D; Soma G
    Biochem Int; 1989 Mar; 18(3):501-8. PubMed ID: 2669759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral vaccination of adenoviruses expressing fusion protein RM4/tumor necrosis factor (TNF)-alpha induces significant tumor regression.
    Wright P; Zheng C; Moyana T; Xiang J
    Cancer Gene Ther; 1998; 5(6):371-9. PubMed ID: 9917092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of three in-vitro refolding methods for human-derived anti-CTLA4 scFv expressed in E. coli].
    Huang Q; Chen L; Zeng L; Wan L; Li S; Lu X; Cheng J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Apr; 23(2):388-91. PubMed ID: 16706373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soybean disease resistance protein RHG1-LRR domain expressed, purified and refolded from Escherichia coli inclusion bodies: preparation for a functional analysis.
    Afzal AJ; Lightfoot DA
    Protein Expr Purif; 2007 Jun; 53(2):346-55. PubMed ID: 17287130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione-dependent pathways of refolding of RNase T1 by oxidation and disulfide isomerization: catalysis by protein disulfide isomerase.
    Ruoppolo M; Freedman RB; Pucci P; Marino G
    Biochemistry; 1996 Oct; 35(42):13636-46. PubMed ID: 8885843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.